This HTML5 document contains 123 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44535588
rdf:type
wikibase:Item
schema:description
artikel ilmiah научни чланак artigo científico научная статья 2013 nî lūn-bûn naučni članak bilimsel makale vitenskapelig artikkel scienca artikolo 2013年學術文章 ১৬ ফেব্রুয়ারি ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vědecký článek article científic wissenschaftlicher Artikel мақолаи илмӣ مقالة علمية نشرت في 16 فبراير 2013 scientific article published on 16 February 2013 tieteellinen artikkeli artículo científico publicado en 2013 tudományos cikk videnskabelig artikel artículu científicu 2013年學術文章 2013年学术文章 научна статия bài báo khoa học 2013年の論文 article scientifique מאמר מדעי artikulong pang-agham 2013年學術文章 2013年学术文章 articol științific 2013年学术文章 scientific article published on 16 February 2013 teaduslik artikkel 2013年學術文章 artigo científico επιστημονικό άρθρο scientific article published on 16 February 2013 2013年學術文章 2013年学术文章 2013年学术文章 2013년 논문 vetenskaplig artikel artykuł naukowy wetenschappelijk artikel บทความทางวิทยาศาสตร์ vitskapeleg artikkel artikull shkencor наукова стаття, опублікована в лютому 2013 научни чланак article scientific articolo scientifico vedecký článok სამეცნიერო სტატია 2013年学术文章 artigo científico
p:P577
wds:Q44535588-A549F7BF-A59B-47C7-9834-FF44121FA566
wdt:P577
2013-02-16T00:00:00Z
p:P2093
wds:Q44535588-F8B8B209-9A29-434D-BE8B-6D27BC8429F6 wds:Q44535588-ED82C12D-CE48-4D6B-9BAA-A4C3079824A1 wds:Q44535588-E799E753-0CE4-44AA-9E1B-3354792E0599 wds:Q44535588-C8A6A524-CA2E-4AC2-9878-2D2AC415847B wds:Q44535588-CB08464D-9B43-4D87-AF47-8E4A07692598 wds:Q44535588-BF41B503-5616-45E8-8FDF-FE4ADAD59692 wds:Q44535588-5620193A-3B16-429E-A6D3-B4A1B472ECDB wds:Q44535588-5F3DD4BB-22C7-4D3D-9A66-CDC9F10ECD28 wds:Q44535588-3B5F66F0-CD3E-44CF-98BD-A76FD2FA1DF8 wds:Q44535588-145F51EC-4DEF-41BF-A069-B216ACB4E955
wdt:P2093
Jacques M Duijs Ellen Lievers Johan W de Fijter Helene Roelofs Meriem Khairoun Jaap Jan Zwaginga Marlies E J Reinders Marieke Roemeling-van Rhijn San W S Wong Willem E Fibbe
rdfs:label
Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy
skos:prefLabel
Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy
schema:name
Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy
p:P50
wds:Q44535588-51C3F6B2-82DC-45B6-B78E-D93B38D280F0 wds:Q44535588-3535CEF1-8355-4DB9-B77E-169F3EB6F348 wds:Q44535588-973A24CB-971B-4366-9EA7-94DBFFFE4DFC wds:Q44535588-6358697B-51BC-4D64-9FC4-685A53FA58AF wds:Q44535588-67353773-75D9-4C3D-9526-D0AD0B75B784 wds:Q44535588-DA33D480-3132-4E1B-B137-E8D0AF972AA2 wds:Q44535588-C15A0764-2294-49A9-B97B-EE4330ADE6B2
wdt:P50
wd:Q114258579 wd:Q114258580 wd:Q91695787 wd:Q47657092 wd:Q40341003 wd:Q50240733 wd:Q47158440
p:P1476
wds:Q44535588-DDD80DE0-61C3-4B29-832B-FEF62E36E3F5
wdt:P1476
Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy
p:P304
wds:Q44535588-D4ED855C-CAF7-40A6-9C86-5A6345E3C598
wdt:P304
663-672
p:P31
wds:Q44535588-18E8F324-2D88-4A82-81B1-29317C31DA6F
wdt:P31
wd:Q13442814
p:P921
wds:Q44535588-F6FE76F0-27E9-4243-9C5B-84139F38BFA4
wdt:P921
wd:Q1054718
p:P698
wds:Q44535588-8D01975C-4B09-4812-9953-75728869030C
wdtn:P698
n12:23419679
wdt:P698
23419679
p:P1433
wds:Q44535588-A21E5E86-DE25-45AA-9547-DADFA27791F7
wdt:P1433
wd:Q5201399
p:P433
wds:Q44535588-A50D52BA-6276-4AA2-934C-A0E9D96BA525
p:P478
wds:Q44535588-F0E77C30-11D3-4F8F-B8C0-74B7D895DC92
wdt:P433
6
wdt:P478
15
p:P356
wds:Q44535588-8596C79D-A4ED-4021-BC4B-263F9FBEF89F
wdtn:P356
n8:J.JCYT.2013.01.010
wdt:P356
10.1016/J.JCYT.2013.01.010
p:P5875
wds:Q44535588-2B35D743-2588-4241-BF0A-D6B2AB25C49F
wdt:P5875
235658314